Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib
Clinical trial NCT00890110 · UNKNOWN
Trial details
- NCT number
- NCT00890110
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.